Kadant Solutions Introduces nForce™ Doctor Blade for High-Performance Doctoring
AUBURN, Mass., April 23, 2019 – Kadant Solutions, a division of Kadant Inc. (NYSE: KAI), announced the launch of its nForce doctor blade, the latest advancement in nanotechnology-enhanced composite doctor blades. The proprietary doctor blade incorporates a tough, metal-reinforced layer and inherent stickie resistant properties.
According to Scott Borges, product line manager for doctor systems, “The nForce doctor blade is ideal for processes using recycled fiber afflicted by heavy contaminants and stubborn stickies. The high-performance doctor blades have been shown to require fewer blade changes and have the potential for reduced operating costs while enhancing overall doctoring and machine efficiency.”
About Kadant Solutions
Kadant Solutions, based in Auburn, Massachusetts, is a leading supplier of doctor blades, doctor blade holders, and doctoring systems for papermaking and other industrial processes. The company’s cleaning and conditioning products are applied to the cleaning of forming and press fabrics and the filtration of process water as well as engineered wet-end products for papermaking.
Kadant Inc. is a global supplier of high-value, critical components and engineered systems used in process industries worldwide. The Company’s products, technologies, and services play an integral role in enhancing process efficiency, optimizing energy utilization, and maximizing productivity in resource-intensive industries. Kadant is based in Westford, Massachusetts, with approximately 2,800 employees in 20 countries worldwide. For more information, visit www.kadant.com.
Safe Harbor Statement
The following constitutes a “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements that involve a number of risks and uncertainties, including forward-looking statements about our customers, products, technologies, and markets. These forward-looking statements represent our expectations as of the date of this press release. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause our actual results to differ materially from these forward-looking statements as a result of various important factors, including those set forth under the heading "Risk Factors" in Kadant’s annual report on Form 10-K for the year ended December 29, 2018 and subsequent filings with the Securities and Exchange Commission.